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Abstract 
Computerised image-analysis was used to 
quantitate small intestinal mucosae from celiac 
sprue and dermatitis herpetiformis patients, 
Gambian children with tropical-sprue-like 
malabsorption, first-degree celiac sprue rela-
tives, and treated celiac sprue patients during 
challenge with a peptic-tryptic digest of 
gluten. A wide range of mucosal appearances was 
observed. Typically, 'flat' lesions (Type 2) 
revealed a reduced number of epithelial 
lymphocytes that were large and mitotically 
active. At the other extreme, mucosal architec-
ture was relatively well preserved (Type 1) but 
surface epithelium contained an expanded popula-
tion of small, non-mitotic lymphocytes, with or 
without crypt hyperplasia. Simil ar changes were 
observed in one-third of celiac re lative s and 
following small dose gluten challenge. Larger 
dose challenges revealed a transition from Type 
1 to Type 2 lesions over a 5-day period. Studies 
in a few patients over 2-4 years showed a 
similar type of progression. A major feature of 
this sequence was early appearance of crypt 
hypertrophy while villi persisted, indicating a 
ro le for factors other than increased l oss of 
enterocytes from surface epithelium. These 
changes parallel the T lymphocyte-mediated 
events in graft-versus-host reactions in 
animals . It is thus concluded that the spectrum 
of immunopathologic changes observed in gluten 
sens itivity is fundamentally a cell-mediated 
effect, the degree of change being contro lled by 
host genetic factors. In becoming flat, it 
appears obligatory for the mucosa to evolve 
through the earlier Type 1 lesion in which crypt 
hypertrophy is a prominent response . 
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Introduction 
The classic studies of the Dutch workers 
Dicke , Weijer s and van der Kamer [24,52] 
established the central role of gluten protein 
in the pathogenesis of celiac sprue (CS). 
Although CS was considered to be a disease of 
children, it became evident, by 1960 [99,105] 
that some adults previously lumped together in 
an amorphous diagnostic group termed "idiopathic 
steatorrhoea", had an identi ca l condition by 
virtue of a simi lar lesion of upper jejunal 
mucosa ( "subtotal villous atrophy"). Thus, CS 
came to be regarded as a life-long disorder 
[84], while the combined use of jejunal biopsy 
and a gluten-free diet subsequently showed that 
after a few years of treatment, complete 
morphological restoration of jejunal mucosal 
architecture could be expected [2,122]. 
The term "subtotal villous atrophy" 
embraced a lesion comprising loss of surface 
villi associated with shortened, cuboidal 
epithelial cell profiles, marked hypertrophy of 
the crypts, and a chronic inflammato ry cell 
infiltrate of the 1 ami na propri a. Another 1 es s 
severe le sion, termed "partial villous atrophy" 
was originally [26,118] considered to be a 
distinct entity intermediate in appearance 
between normal and the more severe "fl at" 
lesion. Although this terminology has unfortu-
nately become engrained in the literature, later 
studies by SEM [63,74,75] and kinetic analyses 
of epithelial cell turnover [ 120,121] showed 
conclusively that there is a progressive 
continuum of mucosal change between the two 
extremes . 
The abnormal epithelial structure in the 
severe lesion seemed compatible with a major 
theory of pathogenesis envisaged by Frazer [37]. 
This proposal saw epithelial eel 1 s, congenitally 
lacking a "peptidase" and hence unable to 
complete the digestion of gluten protein, 
damaged by the direct action of an incomplete 
breakdown product of gluten. This idea is no 
longer consistent with recent concepts of 
digestion, transport and absorption of proteins 
by mammalian intestine [17,56,83,94,111]: not 
surprisingly, there has been little success in 
identifying the missing peptidase [13,95]. 
Furthermore, the gradual realisation that CS 
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patients (i) have antibodies to gluten and 
lymphocytes reactive to gluten protein in vitro 
(ii) exhibit splenic atrophy and mesenteric 
lymph node cavitation (iii) may develop T cell 
lymphomas and (iv) are genetically-predisposed 
by virtue of certain HLA Class II D-locus 
allospecificities, indicated widespread involve-
ment of the immune system in this condition 
[3,21,22,42,45,46,47,48,49,53,55,57,82,92,93,103, 
112,115]. More specifically, the demonstration 
of a rise in the relative density of 
interepithel ial eel l space lymphocytes (EL) in 
untreated CS patients [33] was one of the first 
major studies indicating that CS is primarily an 
immune-mediated condition. 
Interest in the importance of EL was 
stimulated by their close proximity to the 
intestinal lumen, suggesting that they might 
play a major role in "immune surveillance" at 
this strategic host-environment frontier 
[5,25,29,31,72]. With others [18,64,100] we 
initially discovered the presence of blast-
transformed EL within murine small intestine and 
that these lymphocytes have a high mitotic rate 
[46,47,65,67,69,97]. At that time it seemed 
reasonable to suppose that EL were reacting to 
antigen traversing the intestinal epithelium. 
It thus followed that if CS were due to local 
immunisation to gluten peptide s , then similar 
changes in the EL population might be expected 
in the target of immunologically-sustained 
damage - the upper jejunal mucosa [68] . 
The purpose of this review is to summarise 
our principal findings regarding EL populations 
in CS in relation to the background 
morphological appearances referred to above. In 
studyi ng the entire range of "gluten 
sensitivity", which includes patients with overt 
CS [66] and dermatitis herpetiformis (DH) [8], 
first-degree relatives of known CS patient s 
[80], together with the effects of graded oral 
challenges of gluten peptides on treated CS 
patients [58], a much wider spectrum of 
immunopathologic changes has emerged. While 
such studies are still being pursued, the 
results closely parallel events accompanying 
various models of graft-ver sus-ho st reaction 
(GVHR) and allograft rejection in experimental 
animals [32] . It is on this latter background 
that the varied features of the celiac lesion, 
as well as those associated with other 
presumptive 'immune' disorders of the small 
intestine, such as tropical sprue and 
giardiasis, may be more effectively evaluated. 
Together, they suggest that in all these 
conditions, the various degrees of intestinal 
involvement are (i) reflections of T cell 
lymphocyte-mediated attack and (ii) dependent on 
a specific (genetica ll y-mediated) host response 
for their expression . 
Materials and Methods 
Subjects Studied 
Controls. These were either healthy young 
volunteer s (HV) (age range: 20-26); family 
member contro l s of known CS subjects (FMC) (age 
range: 24-58); disease-controls (DC) (age range: 
1664 
18-65) comprising patients referred with 
gastrointestinal symptoms but in whom jejunal 
morphology was judged to be normal and CS not 
considered to be the diagnosis; a group of 
misce llan eous patients (age range : 28- 72) 
accompanied by a 'flat' mucosa (FDC) that was 
not considered due to gluten sensitivity [76]: 
among this group were patients with jejunal 
Crohn' s disease, a -chain disease, small 
intestinal lymphoma and common variable 
immunodeficiency. 
Celiac Sprue. Mucosae were obtained from 
among 25 patient s (age range: 21-68) with 
diarrhea, malabsorption or anemia as a 
diagnostic procedure, and who were shown to have 
a flat mucosa in which the percentage mitotic 
index of EL > 0.2% [69]: note that this index in 
the non-CS flat disease-control group was <0.1% 
[76]. 
Mucosae were also obtained from these 
patients at varying times during treatment with 
a gluten-free diet. At that stage, patients 
were in good health, without malabsorption or in 
need of nutritional supplements, and in whom 
there was histological evidence of improved 
mucosal architecture. 
Dermatitis Herpetiformi s. These comprised a 
group of 30 subjects with pruritic, eruptive 
skin vesicles appearing on face, shoulders, 
elbows and knees, and in whom immunofluorescence 
of uninvolved sk in revealed linear/granular 
deposits of IgA [54]. They were referred by 
physicians at the Manchester Hospital for 
Diseases of the Skin. Treatment was with ora l 
dapsone and gluten-free diet: gluten-sensitivity 
was demonstrated either by marked histologica l 
changes in jejunal mucosa and/or by subse quent 
challenge with gluten, or derivatives thereof. 
First-Degree CS Relatives. A sample of 52 
first-degree CS relatives was s tudied in terms 
of HLA status, mucosal morphology, EL 
populations, and permeability to the probe 
5l(r-EDTA (ethylene diamino tetra-acetate) 
[13,14]. Relatives (symptomatic or asymptomatic) 
with pre-e xisting flat jejunal mucosae 
(prevalence 15.5% of 200 relatives) were 
excluded from this particular study [8] . 
IRJTiunogens 
Gluten. Peroral challenges in healthy volun-
teers and treated CS patients were performed 
with a peptic-tryptic digest of crude commercial 
gliadin (Sigma) as originally described by 
Frazer and coll eagues [38] and modified by Jos 
et al [51] . Dose ranges were 0.1, 0 .5, l, 1.5, 
3.0, 6gm. 
Contro l . 500mg of B-lactoglobulin (BDH) was 
used as a control challenge immunogen. 
Challenge Protocol 
Pat ients and controls were admitted to a 
metabolic ward for 5 days [58]. On the morning 
of day 1, a cont rol jejunal biopsy was performed 
and at 10pm the se le cted dose of immunogen was 
given by mouth. The first post-challenge biopsy 
was performed at 10am on the morning of day 2, 
i.e . , 12h after the challenge immunogen was 
ingested. Subsequent bio psies were obtai ned on 
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the morning of the 3 remaining days, at 36, 60 
and 84h after chal l enge. 
Hi stolog ic Techni que 
Mucosal tissue was obtai ned under fluoro-
scopic control from the first loop of jejunum by 
Watson, or Quinton hydaulic mul tiple-biopsy, 
instruments. Specimens were quick ly retrieved 
within 0.5 min, gently spread on cards and fixed 
in either Dalton's chrome-osmium fixative [20] 
or (more recently) with 2.5% ultrapure 
glutaraldehyde buffered with O.l M sodium 
cacodylate to pH 7.2: these specimens were 
post-fixed in 1% osmium tetroxide for 1 h. 
All specimens were routinely processed into 
Araldite plastic, sectioned at lµm on Sorva l l 
MT2-B or Reichert OMU-3 ul tramicrotomes and 
stained with toluidine bl ue. Six consecutive 
lµm sections were mounted per slide and lOµm 
st eps were discarded between successive slides. 
Only one section per slide was analyzed, the one 
chosen being least subject to preparative or 
technical artefact. The remaining sections 
served for verification of cytologic detail if 
required, while the intervening lOµm step 
ensured that no cell was counted twice. With 
some analyses, several parts of the chosen 
section were used, but no observations were 
duplicated on the same part of individual 
sections . Care was taken to ensure that the 
bulk of the speci men was sectioned vertica l to 
the surface mucosal pla ne . Appropriate 
micrographs were recorded on Ilford FP3 high 
grain film through either Zeiss "Photomicroscope 
III " or Olympus BH2-S research microscopes. 
Morphometric Analysis of Mucosal Speci mens 
Sections were examined through an oil-
immersion objective (xlOO) and analyzed with a 
MOP-Videoplan (Kontron-Reichert) image-analysis 
sys tem. All measurements as detailed below, were 
related, dir~ct 2y or indirectly, to a constant test area (10 µm) of muscularis mucosae [71,91]. 
Mucosal Compartment Volumes (V5 E~CR-l-
~LP1· For the determination of surface 
epithe l ial volume (VsE), crypt epithelial vol ume 
(VcR) and lamina propria volume (VLP) per 
specimen [91,79,23], the appropriate sectioned 
profiles in lµm epon sections were outlined with 
the scr ibing cursor, and individually cumulated 
relative to a total length of 100 x lOOµm (10mm) 
muscularis mucosae, thus approximating the test 
area. Coefficients of variation for successive 
measurements per 100mm muscularis per specimen 
were <10%: these calculations are automatica l ly 
inc l uded in the print-out by the manufacturer's 
soft-ware programme. 
Grouped values for VsE, VcR and VLP were 
expressed in terms of their equivalent cube 
vol umes [71], and depicted graphical ly by 
drawing their areal faces to scale (Fig. 1). 
Mean Epithelial Diameters (DNl. The nucl ear 
profiles of 100 EL were traced with the cursor 
per specimen: in previous work it was shown that 
this popul ation size was sufficient to achieve a 
constant mean ± SD. The initia l crude 
distribution for nucl ear diameters was 
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Fig ure 1. This diagram represents mucosal 
components for lamina propria, surface and crypt 
epithelium in control subjects and patients with 
untreated, and treated celiac sprue, expressed 
as equivalent cube volumes6 T~e means for each group of measurements (xlO µm) accompany each 
cube, the faces of which are drawn to scale to 
permit quantitative comparison. All measurements 
are controlled by reference to the constant test 
area of muscul aris mucosae . 
[41] by adding the smallest profiles (left hand 
25% of distribution) determined by scaling 
existing values up to a line joining the zero 
or igin with the half-value of the mode. 4he mean of this di s tribution was multipl ied by ITT 
to correct for imperfe ct (non-sagit tal) 
sect ioning [117]. In this way, the true mean 
nuclear diameter (DN) of EL (surface or crypt 
epithelium) per specimen was obtained. 
From each corrected distributi on, the 
percentage of nuclei with DN > 6µm (% 
'immunoblastoid' lymphocytes) was obtained. 
Calculation of Absolute EL population (Nv) 
~SE or VciJ · In attempting to determine the 
absolute number of a population of cells 
contained within a defined tissue component, of 
volume V, the true ctiameter of those cells must 
be known [77], since each sectioned "profile" of 
a cell observed in a section of known thickness 
(t µm) represents only a fragment of the whole 
cell. It has been shown [117] that all 
particles (diameter, D) whose profiles appear in 
any finite section of t µm thickness are 
contained in a superslice whose overa l l 
t hickness (or ' effective sect i on thickness ' EST) 
is given by the relationship: 
EST (t + D)µm (1) 
Since DN for sur f ace or crypt EL was 
calculated, the total number of EL (N) occupying 
VsE or VcR per specimen was obtained by counting 
EL profi l es relative to 100 x lOOµm muscularis 
mucosae per specimen: thus Nv [100 x 
( l □□;EST)] units of tissue vol ume. Nuclear 
profiles were used in calcu l ating EST because 
they are more nearly circular in sectioned 
M.N. Marsh 
profile and hence more accurately measured . 
Percentage Mitotic Index (%MI) of EL. The 
percentage mitotic index was calculated from the 
number of metaphases observed in a total sample 
of 3000 EL in surface epithelium only per 
specimen [66], thus avoiding confusion with 
mitotic precursors in the generative crypt 
epithelium. Furthermore, it has been shown [113] 
that once ascended onto the villi mature 
enterocytes, goblet cells and argentaffin cells 
cease mitotic activity. In flat mucosae, 
proliferative epithelial cells may occur 
throughout the length of the hypertrophied 
crypts. With such specimens, scoring of mitotic 
figures was strictly confined_ to surface 
epithelium, crypt mouths being avoided. . . 
In order to determine rates of EL mitosis 
in vivo [66], four intramuscular injections _ of 
1.2mg colchicine at hourly intervals were given 
to selected controls, and CS patients, both 
before and during treatment with a gluten-free 
diet. Jejunal biop s ies were performed before and 
at variable time-points during the 4h oeriod of 
mitotic blockade . The total dose (4.8 mg) 
administered was considered suitable for this 
purpose and was controlled by being shown to be 
effective in arresting crypt epithelial cell 
mitotic activity during the study period [66]. 
Results and Discussion 
Untreated CS Disease 
In untreated CS (n = 14), mean corrected 
nuclear diameter (ON) of surface EL was 5.6 
± 0.2, compared witn 5.0 ± 0.1, 5.0 ± 0.2 and 
4.9 ± 0.1 f or healthy volunteers (HV, n 10), 
family members (FMC, n 10) and disease 
Figure 2. In the established CS lesion, EL 
reveal an increase in mitotic activity (LH 
panel, arrow) and increase in size: some have 
an 'immunoblastoid' appearance (RH panel, 
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Figure 3. Percentage mitotic indices for EL in 
various categories of human small inte sti nal 
biopsies are illustrated. In the majority of 
control biopsies mitotic EL are rarely seen, 
while in gluten-sensitised patient s (coeliac 
disease, dermatiti s herpetiformi s OH and 
eel iac-associated lymphomas) with Type 2 lesi ons 
( ■ ) the inde x usually exceeds 0.2%. OH patient s 
with Type 1 le sions ( □ ), immunodeficiency (• ), 
~on-gluten-induced lymphoma (.a.) or carcinomas 
(X) , differ insignifica ntly from controls: solid 
symbols denote 'fl at' biopsies. EL in the 
patient with combined CS and immunodeficiency 
( II) ) behaved l i ke other CS lymphocytes. Given a 
flat biopsy, an elevated index> 0.2% among EL 
is a useful presumptive marker for CS disease. 
contro l s (DC, n 10) with normal mucosal 
struct ure, respectively (p < 0.001). With 
remission on a gluten-free diet, ON for treated 
CS patients returned to the normal range. These 
data clearly show that the increased proportion 
of immunoblastoid cells (Fig. 2) in untreated CS 
shi fts the distribution to the right, returning 
to overlap the normal di strib ution for ON once a 
singular change in diet, removal of gluten, had 
occurred [66]. 
In determining the% mitotic index (MI) of 
EL, values greatly exceeding 0.2% (Figs. 2,3) 
were usually observed in untreated CS patients 
[66,69], while a variety of control subjects, 
including some with flat-mucosae had lower MI < 
0.1% [76]. In treated CS patients, MI for EL in 
surface epithelium fell below the arbitrary 
cut-off point (0.2%). Thus it was concluded 
that activity of EL was reduced by the removal 
of a single antigen only from the patients' diet. 
The use of colchicine served to highlight 
both the high basal mitotic activity of EL (Fig. 
4) and the increased rate of arrival of new 
cells into metaphase with time (Fig. 5). The 
Inwnunopathology of Intestinal Cell -Mediated Responses 
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Figure 4. This figure illustrates 1~i to tic 
indices (vertical axis ) for EL in control and 
CS patients, before and after treatment. Basal 
activity in 10 controls was zero, and no 
additional metaphases were observed after a 4h 
colchicine blockade. In contrast, mitotic 
indices in CS are raised, with a marked increase 
with colchicine: after treatment, mitotic 
indices fall almost to control values. 
dynamics of such changes were markedly reversed 
by gluten-restriction [66]. 
An investigation int o the EL of crypt 
epithelium [79] was prompted by an observed 
increase in the flattened mucosa of endemic 
tropical sprue patients [77,9 8]. Despite a 3-5 
fo ld increase in VCR compared with various 
control mucosae (1.7 x 10 µm vs 0.5-0.6 x 
106µm3), a considerably elevated population of 
EL ( ~ 180) was observed (Fig . 6), confined 
predominantly to their upper regions (Fig. 7). 
Even allowing for the scaling-up of control 
crypt volumes to those of untreated CS crypts, 
the latter sti ll contain an excess of EL over 
controls that is considered to be gluten-
induced. In parallel with their counterparts in 
surface epithelium, ON for crypt EL was 5.7 ± 
0.2, compared with controls (4.9 ±0.1, p < 
0.001), reverting to the control range with 
dietary gluten restriction . Note also the 
marked increase in large immunoblastoid cells 
(DN > 6µm) (Fig. 8). 
Paradoxically, although the population of 
crypt EL was considerab ly elevated irrespective 
of hypertrophy of crypt epithelium and fell on 
treatment [79], the results for surface 
epithelium were different, the total population 
of EL in untreated CS mucosae being somewhat 
lower (250} than the means (300-350} for each of 
the various contro l groups [66]. Furthermore, on 
treat ment, the populat ion size for EL in surface 
epithelium increased to a mean of 370, while 
that in crypts fell ( 180 to 60). 
Dennatitis Herpetifonnis 
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Figure 5. This illustrates use of multiple 
biopsies during a 4h period of colchic ine 
blockade in establishing rates of EL mitosis 
(measured by % mitotic index) in two CS 
patients, before (upper curves), and after 
(lower curve s) , treatmentwith dietary gluten 
restriction: Note alterations in rates of 
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Figure 6 . Crypt lymphocytes (N) in untreated CS 
(UCS) are markedly elevated over all other 
control groups (HV - human volunteers: FMC -
famil y member contro l s: NOC normal 
disease-controls: FDC - flat-disease contro l s) 
and fall after treatment (R CS). Data reoresent 
absolute population siz es refated to 104µmc test 
area of muscularis mucosae. 
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Figure 7. This representative lµm toluidine 
blue-stained micrograph illustrates infiltrated 
crypt epithelium in untreated CS. Note marked 
heterogeneity in size and appearance s of 
lymphocytes (EL}. Bar= lOµm. Note that EL 
occupy upper zones of crypt epithelium. 
morphologic changes were wrought on 
mucosa by gluten compared with CS. 
i nvestigators [12], especially Fry et al 
had emphasised that the majority of DH 
have a virtually normal villous 





st r uct ure 
It was instructive to apply image-analysi s 
techniques to the DH lesion in patients before 
gluten restriction in order to compare 
background mor phologic changes with those 
i nvolving the EL pool within surface (v illus) 
and crypt epithelium (Fig . 9). The data are 
ranked according to VsE, thus demonstrating the 
progressive flattening of villous structure to a 
degree identical to that seen in untreated CS 
disease. 
It is interesting to note that crypt 
hypertrophy appears early in the series and is 
present in some specimens whose surface 
epithelial volumes (VsEl had not fallen below 
the lower 95% confidence limits for control 
mucosae. This raises the intriguing possibility 
that crypt hypertrophy is not a compensatory 
response to an exaggerated rate"of migration and 
desquamation of surface enterocytes that 
characterises severe villous flattening, but 
rather is due to other mechanisms, as yet 
unidentified. Thus, the validity of the analogy 
between enterocyte loss followed by crypt 
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Figure 8. Like sur face epithelium in CS, crypt 
epithelium al so contains a high proportion ( ~ 8%) 
of immunoblastoid EL over all other group s (see 
Figure 6}. Note that EL nuclear diameter s (> 
6µm) provide a more accurate assessment of cell 
size than cytoplasmic diameters( > 9µm) which 
are subject to greater sectioning errors as 
overall size increases. In treated (RCS) 
cases, size of lymphocyte s rapid ly returnsx to 
control value s. 
( haemolysi s) leading to compensatory bone marrow 
growth, may be incorrect. 
In terms of EL, it can be seen that the 
vi lli to the left hand margin of the diagram 
contain markedly increased population s of EL, 
although the se are small and non-mit otic. As 
VsE fall s , the absolute number of EL drops, so 
that for flat mucosae (right-hand margin), 
values lie around the low-normal range . In this 
se tting, however, EL are large and highly 
mit ot ic and thus identical in behaviour to tho se 
in the classic CS le s ion, as detailed above . 
Conversely, note that as the cry pts hyper trophy, 
their content of EL progressively rises: 
furthermore, with severe l es i ans, crypt EL 
become larger, as in untreated CS crypt s [79]. 
Malabsorption Syndrome in Gambian Children 
In a collaborative study organised by the 
Dunn Nutrition Laboratory, Cambridge, UK, we 
have been analyzing jejunal mucosae from young 
children from villages in the Fajara region of 
Gambia. These children have a severe 
malabsorption syndrome (not apparently due 
either to dietary causes, giardiasis or an acute 
infectious enteritis) in whom a pilot study 
revea led a jejunal lesion reminiscent of coeliac 
disease: they might therefore provisionally be 
deemed to have a chronic 'tropical sprue-like' 
illness. 
Our preliminary data are displayed as for 
DH patients (Fig. 10} with vil lou s volumes (VsEl 
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Figure 9. Mucosae from 32 untreated DH patients 
are arranged in decreasing order of surface 
epithelial volumes (V5 E), together with their 
corresponding crypt epithelial volumes (VCR), as 
indicated on LH axis (xl0 6µm3 ). The three sets 
of horizontal paired l i nes represent 95% 
confidence 1 imits for lowest control V SE and 
highest CS VsE, and uppermost crypt epithelial 
volume (VsE) for control mucosae. RH axes are 
logarithmic scales for absolute populations of 
EL in surface [Nv(SEJL and crypt [Nv(CR)] 
epithelium. 
Left hand villi that are within normal range 
contain raised EL populations: population size 
for surface epithelial EL falls as mucosae 
flatten (RH side). In contrast, crypt EL 
abruptly rise above upper reference range 
(horizontal single line) in at least seven 
mucosae whose vil l ous volumes stil l lie within 
the lower 95% confidence limit, but whose crypt 
volumes exceed normal control values. As 
VsE gradually falls, there is a slig ht 
progressive increase in Nv(CR)-
ranked from left to right: note the surpris ing 
simi larity between both sets of data. Notice 
also the hypertrophy of the crypts in many 
biopsies in the absence of major reductions in 
VsE, and that they have high EL populations. 
Likewise, villi on left of diagram contain a 
markedly increased population of small, 
non-mitotic lymphocytes while with more severe 
lesions a fall in Nv(SE) occurs. 
The similarity in the drift of the mucosal 
chanqes (from L to R in both conditions) hints 
at a common mode of progression, and hence 
pathogenesis. However, the difficulty in 
interpretation is that each 'framework' is 
static and fails to answer the most important 
question arising from these data, i .e., in 
becoming flat is it obligatory that the mucosa 
passes through an identical series of changes in 
each patient. There is currently no answer _to 
this important question: the natural in vivo 
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Figure 10. The format of the diagram is 
identical to Figure 9, but illustrates data from 
17 Gambian children with "tropical sprue" type 
malabsorpt i on. Several left hand villi are of 
normal volume, contain a high number of EL and 
are associated with markedly hypertrophic crypts 
bearing their own increased population of 
lymphocytes. While crypt EL [Nv(cR)] remain 
above upper reference range (hori zonta l line), 
note that surfac e epithelium lymphocytes 
[Nv(SE)] tend to drift downwards into control 
range (be l ow horizontal line) as mucosae 
flatten. There is a striking re semblance between 
these data and the immunopathological features 
in untreated DH mucosae (Figure 9). 
period over which it occurs, has never been 
observed. Note, however, that the reverse 
proce ss during dietary gluten exclusion, is 
surprisingly long and require s 3-12 months on 
average for complete resolution in children [2], 
and between 1-5 years in adult coeliac patients 
[107]. One way of elucidating this problem 
directly is by gluten-challenge. 
The Inmunopathologic Effect of Gluten Challenge 
Although much has been published on gluten 
challenge [19], all studies when evaluated 
together can be seen to lack uniformity of 
approach, s ince much of the impetus has been 
purely diagnostic, i .e ., to flatten the mucosa 
in order to prove gluten-sensitivity . 
In our laboratory it was thought desirable 
to approach the problem in a more systematic 
way, since it was argued that if the cel_iac 
lesion is due to cell-mediated immune mechanisms 
then a series of graded challenges (analogous to 
performing a Mantoux test) might reveal detailed 
information about the sequence of changes 
reflecting the evolution from normal villous 
architecture to that of avillous flattening. 
We therefore set out to chal lenge small 
groups (~6) of well-treated CS patients with a 
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Figure 11. These are group mean data for 
treated CS patients challenged orally with 
Frazer fraction 3 (peptic-tryptic digest of 
gliadin) at doses of 100-1500mg per challenge . 
There is a dose-dependent, time-related 
increment (shown on vertical axis as net 
percentage change over pre-challenge control 
values) in surface epithelial lymphocytes . The 
lymphocytic infiltrate comprised small, 
non-mitotic cells that had virtually ceased by 
36h post-challenge. There was no response to 
the control protein S-lactoglobulin (horizontal 
dotted line ). 
peptic-tryptic digest (PTO) of gliadin L58J and 
to observe the effect s of each dose of PTO over 
a 5d period, as described in Methods . These 
studies are still progressing. 
In the smaller challenges (Fig . 11), in 
which oral doses of either 100, 500, 1000 or 
1500mg of PTO were employed, a dose-dependent, 
time-related accumulation of small, non-mitotic 
lymphocytes into surface epithelium was observed 
[58]. Despite the influx of EL, there was no 
reduction in VsE, rise in VcR, nor change in 
total length of basement membrane (per 104µm2 
muscularis mucosae) in any specimen analyzed. 
It should also be noted that CS patients did not 
react to S-LG, while control subjects showed no 
response to either immunogen. The maximal 
increment in EL was observed at 12h post-
challenge, the effect having largely disappeared 
when the next biopsy was obtained at 36h 
post-challenge . 
With a 6gm PTO oral challenge, a consi-
derably more interesting set of data was 
obtained, as exemplified by one of the patients 
in this group . The data are displayed as for DH 
(Fig. 12), although the difference now is that 
they represent a sequential series of mucosal 
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Figure 12. This diagram illustrates sequent i al 
immunopathologic changes in small intestinal 
mucosa in a gluten-sensitive patient challenged 
orally with 6g Frazer fraction 3 (peptic-tryptic 
digest) . Format as described in Figure 9. The 
control (pre-challenge) biopsy (a) is normal . 
At 12h and 36h post-challenge (b,c) there is 
already marked crypt hypertrophy exceeding upper 
95% confidence limit for control crypt volumes 
(VCR) while villi are still in control range. 
Nevertheless both compartments are subject to 
major rises in EL content, but vihereas cr-ypt EL 
population [Nv(cR)] remains elevated, that in 
villi [Nv(SE)] falls as villi approach 'flat' 
range (d,e). EL in specimen e revealed an 
increa se in size and mitotic activity. 
At 12 and 36h pos t-challenge there i s no 
statistical change in villous height (VsE 
remains constant), but there is a doubling of 
crypt volumes (VcR) which persists throughout 
the challenge . At 60-84h, there is considerable 
loss of villous height although true flattening 
fails to occur . The events occurring within the 
EL pool are striking. At 12h the absolute 
population of EL (Nv(SE)) in villous epithelium 
has almost doubled (note log scale) although the 
lymphocytes are small and non-mitotic while at 
later times, they gradually fall in number in 
parallel with the progressive reduction in VsE· 
In the crypts, EL rise throughout the challenge 
and remain elevated at 84h. At 84h, their size 
has increased and the rate of mitosis has also 
begun to accelerate. 
In dynamic terms, we see for the first time 
the temporal evolution of events leading to 
mucosal flattening and which also precisely 
recapitulate the static picture suggested by 
grouping mucosae as in DH (Fig. 9) and the 
Gambian children with sprue-like malabsorption 
(Fig. 10). Although these challenge studies are 
continuing, there is already strong evidence to 
show that the evolution of a flat mucosa 
requires progression through a series of 
specific changes. Most notable is the 
observation that crypt hypertrophy is an early 
event, and not primarily a compensatory response 
to villous flattening with its implied increased 
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Figure 13. Initial biopsy (panel a) shows normal villi with considerable infiltration of epithelium 
by small, non-mitotic EL (panel b}. Second biopsy (panel c) reveals intermediate le sio n with "low" 
villi. Final biopsy (panel d} is characteristically flat with epithelium containing both mitotic 
(panel e, upper segment) and immunoblastoid (lower segment) EL. This sequence, somewhat simi la r to 
those depicted in Figure 12, evolved over a period of ~4 years. Magnification bar s: a,c,d l00µm: 
b,e = l0µm. 
desquamation and loss of surface enterocytes. 
Natural Evolution of the CS Lesion 
The above studies stil l invite the criticism 
that the dynamic spectrum of mucosal changes 
brought about by graded challenges with gluten, 
however interesting, represents an artificial 
model of flattening . However, we have observed 
certain patients in the University Department of 
Medicine at Hope Hospital, in whom a s imilarly 
evolving series of mucosal changes was observed 
over several years. An example is shown (Fig. 
13) of mucosal biopsies obtained from a 
60-yr-old lady who presented us with a 20-yr 
history of steatorrhea and nutritional deficien-
cies, with an initial biop sy revealing normal 
vi ll ous architecture (s ubsequent review in our 
laboratory showed epithelium full of small, 
non-mitotic (%MI zero) lymphocytes (Figs. 
13a,b}. No spec ific diagnosis had been made, but 
gluten restriction caused prompt improvement. 
She relapsed six months later and pancreatic 
extracts were added. Two years later (Fig. 13c} 
a further biopsy showed 'ridged' villi (%MI 
0.03) and like the first, was thought to be 
normal: an unrestricted diet was advised. This 
led to a rapid increase in diarrhea within six 
months, and after another year she was referred 
to our Unit, where a third biopsy (Figs . 13d,e ) 
now revealed complete flattening, and large, 
mitotic EL (%MI = 0.5). Nutritional supplements, 
anti-diarrhea l s and strict gluten restriction 
swiftly brought her into remission, with 
improved well-being and subsequent weight gain. 
She remained well until lost to follow-up, but 
refused additional investigative procedures 
during that time. 
The presumptive diagnosis was celiac 
disease. Nevertheless, her mucosal biopsies (if 
considered to be representative) showed a 
hitherto unrecorded progression from villous 
pattern with lymphoid infiltration of epithelium 
to a classic flat lesion containing mitotic, 
'immunoblastoid' EL, evolving over a period of 
3-4 years. A similar mucosa l progression, 
evolving more rapidly within two years, was 
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observed in biopsies submitted to us for review 
on another lady with long-standing malabsorp-
tion: her last biopsy, before gluten 
restriction, was flat and agai n showed 
characteristic proliferative activity of EL. 
Both cases invite the suggestion that the 
temporal evolution of the classic CS lesion may 
involve an initial phase similar to (i) that 
evoked by small-d ose gluten chal lenge s and (ii) 
appearances noted in some first-degree CS 
relatives. 
First-Degree Celiac Sprue Relatives 
Several extensive family st udies have 
revealed a prevalence rate of either symptomatic 
or asymptomatic ( 'latent') celiac sprue with 
classical 'flat' biopsies among 10-15% 
first-degree relatives [62,90,108, 30]. We have 
recently completed a study of 52 fir st-degree CS 
relatives [80] in terms of HLA st atus and 
intestinal morphology, epithelial lymphocyte 
populations and permeability to 51 Cr-EDTA. 
That an increase in intestinal permeability 
predisposes to CS disease was suggested by its 
persistence in several people whose mucosal 
biopsies were morphologically normal as a result 
of many years of gluten restriction [80,6]. 
Given the hereditary-genetic background to CS 
disease, it was argued that first-degree CS 
relatives might be expected to show defects in 
permeability if the latter is an important 
risk-factor in pathogenesis. We were careful to 
exclude from study all relatives who had al ready 
been shown by jejunal biopsy to have a flat 
biopsy, the prevalence rate in our local 
population (15.5%) being similar to that 
elsewhere in the UK and world. 
None of the 52 relatives st udied had any 
abnormality in villous morphology, and 
permeability was within normal limit s (24h 
excretion of 51 cr < 3%). Unexpectedly, 38% of 
these individual s revealed villous epithelium 
containing an increased population of small, 
non-mitotic lymphocytes: the numerical range 
(413-1002) exceeded the 95% upper confidence 
limit s for control biopsies, within which the EL 
population s of the remaining CS relatives fell 
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Fi gure 14. In a study of first -deg ree CS relatives, some were found to have a normal vi llu s-be aring 
mucosa (pane l c) in which epithe lium was heavily infiltrate d by small, non-mitotic lymphocytes (panel 
d). 
Mucosal appearance s i n the remainder were within normal limits (panel s a,b). Bars: panels a,c 
lOOµm: panels b,d = lOµm. 
(78-395) (Fig. 14) . 
The lymphoid infiltrate did not appear 
rel~ted to HLA stat us, s ince the frequency of 
DR3 individual s in the normal 'group' of 
relatives was 50% thus providing an adequate 
control for the second group with in creased 
numbers of vi ll ous EL. Furthermore, it was 
notable t~at two individuals i n the latter group 
were DR3 . Sin ce a l arge proportion (15.5%) of 
CS re l ati ves wit h f l at mucosae were excluded 
fro m this study, it is unclear whether the high 
lymphocytic infi l trates could be a progressive 
les i on, or at l east a "marker" i ndi cating 
development of a flat lesion at some future 
date. Such a view is al so suggested by the 
case-h i stories recorded in the previous section. 
What is evident from this st udy i s that a 
lymphocytic i nfil tra t e into villous epithelium 
does not necessar ily cause either struct ural 
abnormalitie s nor alterations in mucosal 
permeability. Other fa ctors may thus be required 
for full disease expression: the natu re of such 
factors i s at pre sent unknown. 
Extended Discussion 
Morphometric Considerations 
The result s i n all the se studies derive 
from a computerised morphometric syst em of 
analyzing inte stinal mucosa , in which x,y, z 
coordinates are proje cted into the ti ss ue 
sections. The x,y coordinates define a constant 
test area (104µm2 ) that overlies the musculari s 
mucosae, while the z scalar controls structural 
measurements in the vertical component of the 
mucosa. All data, obtained by drawing around 
profiles observed in the 2-dimensional plane of 
the section, are always related to a known 
length of musculari s mucosa while repeated 
measurements permit a statistical reconstruction 
of the origina l (3-dimensional) structure. A 
relative coefficient of variation < 10% 
indicates that sufficient measurements have been 
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made for any tissue component. The three 
stru ct ural components of interest are (i) 
surface epithelial volume ( V sE) (ii) crypt 
epithelial volume (VCR) and (i ii) volume of 
lamina propria (VL~ . Thus, irrespective of the 
degree of abnormali ty (z) pre sent in any 
speci men, its component volumes are calculable, 
valid and comparat ive, si nce they are always 
related to the same test area (x,y) of 
muscular i s mucosae (Fig . 1) . This diagram also 
shows, despite the irregular shape of those 
components, that they may be simpl y displayed, 
quantitatively, as cubes of equivalent vol ume. 
A simi lar approach was used by Guix et al [43] . 
The use of cubes provi des a convenient 
model for evaluating ce ll type s within a given 
str uctural component. Component volume, V, 
number of cells (N), and their resultant dens ity 
(D) per unit volume is give n by the relation D 
N/V (Fig . 15) . This simple relationship permi t s 
constr ucti on of volume-den sity curves [91] and 
evaluation of the effects of varying one 
component in re l ation to the other quantit ie s. 
For example, it was shown [43,66 ] that the 
(abso lute ) EL populat ion in untreated CS mucosa 
lie s at the lower limit of normal. When EL are 
'counted' by reference to epithelial cell s [33], 
a measure of density is obtained, which i s not 
the same as absolute number, i.e., D F N. Wi th 
our mathematical model, values of VsE and NsE 
for a normal mucosa can be calculated: if V is 
then progres s ively reduced to values 
commensurate with a flat mucosa while N is held 
constant, the effect of volume reductions on D 
can be examined (Fig . 16): thi s illustrates how 
density rapidly rises as the mucosa flattens 
although the actual s ize of the lymphocyte 
population has not altered: similar events 
clearly occur in celiac sprue. 
In contrast, crypt EL populations in CS are 
increased presumably because crypt epithelium 
does not exfo li at e. The decrease in surface EL 
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Figure 15. In addition to displaying mucosal 
volumes 1n terms of equivalent cube volumes 
(Fig. 1), this model more effectively 
illustrates the relationship between epithelial 
volume (VE), the absolute number of contained 
cells (N) and their resultant density D, in 
terms of the relationship D = N;v. 
Although CS epithelial volume (V"E) is 
decreased relative to control mucosae (V'E) 
their populations of EL are approximately 
equivalent (N1 = N2 ) , such that the density of 
CS cells D2 exceed D1, the density in control 
mucosae: these concepts can be further exploited 
as demonstrated in Fig . 16. 
populations as flattening occurs is probably a 
reflection of the rapid desquamation of surface 
epithelium which removes EL at a rate greater 
than they can be replaced. This is, of course, a 
speculative deduction and no true data exist to 
support or refute it. 
Type I and Type II Mucosa] Lesions in CS 
It is now evident that two distinct 
extremes of mucosal change exist . The type I 
comprises normal villi whose epithelium is 
filled with numerous, small, non-mitotic 
lymphocytes. This occurs in (i) many DH cases 
(Fig. 9), in some 1° CS family relatives (Fig. 
14), and in treated CS patients challenged 
orally with FF3 in low dose (0.l-l.5g) (Fig. 
11). Conversely the type II lesion is seen in 
untreated CS, and a small proportion of DH 
patients who may have a severe lesion with, or 
without, accompanying malabsorption (Fig. 9). In 
Type II lesions, the mitotic activity and mean 
size of surface, and crypt, EL are increased 
(Fig. 17). 
Some preli minary evidence is presented to 
suggest that the evolution of a type II 'flat' 
lesion requires transition through an earlier 
type I lesion as demonstrated (i) by our 
sequential challenge data (Figs. 11,12) (ii) in 
some patients spontaneously (Fig. 13) and as 
hinted at (iii) by the graphica1 representation 
of mucosae in DH (Fig. 9) or the malabsorption 
syndr0me in Gambian children (Fig. 10). Clear ly, 
although many details require further 







Figure 16. These graphs i llustrate the 
important relationship between cell (EL) density 
(expressed as Nv,E on vertical axis) and 
epithelial volume (VE) (shown on horizontal 
axis) while N remains constant. As VE is 
progressively reduced, the density of EL changes 
little through the range for control values (VE) 
(open box) but rises acutely and 
disproportionately when VE moves through the 
range typical of flat mucosae (shaded area). 
This model emphasises the dangers inherent in 
expressing cell population sizes in terms of 
densities rather than absolute numbers. 
upon which these changes occurs is becoming 
evident . 
Mechanisms of Villous Flattening 
Although we are still not in possession of 
all the factors that result in villous 
flattening, severa l important lead s have been 
established. Firstly, the T cell dependence of 
villous flattening was demonstrated several 
years ago in immunologically-driven models 
involving worm infestations of rats 
(Nippostro ngylus brasiliensis) [34,35]. Further 
s tudies have elaborated on these earlier 
experiments, involving either allograft 
rejection or graft-versus-host reaction (GVHR), 
and have confirmed the effects on mucosal 
architecture [60,61]. In these studies, the 
occurrence of crypt hypertrophy before any 
villous shortening is apparent, was carefully 
documented and emphasised as a major early event 
in these reactions. 
Allograft Rejection. Heterotopic grafts of 
fetal intestine are sterile and la ck their 
normal complement of lymphoid cel l s: thus while 
the graft stroma is of donor origin, the 
lymphoid infiltrates during rejection are 
derived from the host [32]. In these 
experiments the early onset of crypt hypertrophy 
was initiated by increases in crypt cell 
proliferation from day 3 on~1ards. A 
statistically significant reduction in vil lou s 
height was generally only evident during the 
second week after engraftment [60,61]. 
Accompanyi ng the early crypt changes was an 
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Figure 17. Two distinctive patterns occur at 
each end of the gluten-induced spectrum of 
mucosal insults. 
The Type 1 le sion, comprising normal villi 
containing a large population of non-mitotic, 
small lymphocytes is seen in CS patients after 
small dose challenges; a large proportion of DH 
patients; and in some 1° CS relatives. The 
established Type 2 'fl at' lesion, comprising 
large, highly mitotic EL is seen in CS disease 
and some DH patients: the other feature of this 
lesion is that while the size of the EL 
population in crypt epithelium is markedly 
increased, that in surface epithelium lie s 
within the control range: these differences may 
be due to increa sed rates of enterocyte 
exfoliation from the surface epithelium only. 
increase in lamina propria lymphocytes, close ly 
followed by an infiltrate of lymphocytes into 
surface epithelium [34]. These appearances are 
identical to the type 1 CS lesion. 
Allograft rejection represents a phenomenon 
that is (i) thymus- dependent and (ii) in which 
the extent of tissue damage is related to the 
degree of histocompatibility differences between 
host and graft [110]. Analogically, it could be 
stated that as the "challenge dose" increases, 
progressively more severe intestinal damage is 
produced. Anti-graft (cytotoxic) antibody is 
not involved [28] . 
GVHR. Inte stina l damage is produced, along 
with other tissue effects, by injections of 
alloreactive T lymphocytes and is conveniently 
measured by the spleen index [106]. Avoiding 
recognition of donor lymphocytes as foreign by 
the host-recipient can be achieved with the use 
of neonatal animals ( "immunodeficient"), 
irradiated hosts or semi-allogeneic chimaeras 
(F 1 hybrid host) [32]. 
Although in adults (CBA x BALB/c) the 
effects on intestine are not marked, in neonatal 
mice crypt hypertrophy and increased crypt cell 
production (which correlate direct ly with spleen 
index) occur without evident effect on villus 
size. However EL populations rise significantly 
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within 24h: later on, some 
blast- li ke appearance and mitotic 
present [86,87,32] . Again, these 
the type 1 CS lesion. 
EL assume a 
cells are also 
events recall 
Other experiments have shown that enter-
ocyte damage in GVHR is not due to T 
cell-mediated cytotoxicity [32,11,36]. During 
GVHR there is a boosting of NK cell activity and 
recruitment of such cells into intestinal 
tissues f.88]: however depletion of NK cell 
activity, either in host or donor, fails to 
prevent the anticipated immunopathologic effects 
[116]. Thus it seems that the latter are due to 
soluble mediators released by activated graft T 
cells coming into contact with host-derived 
lymphocytes and macrophages [27,85]. The cells 
initiating the reaction are Lyt l+ (T helper) 
cells restricted by I-A (MHC Class II) gene 
products: these are DTH effector T cells [89,44] . 
IFN-y, a lymphokine secreted by activated T 
lymphocytes, is one agent known to stimulate the 
constitutive expression of I-A (class II) 
antigen by crypt and surface epithelial cell s 
[4,16]. Thus I-A expression by enterocytes is 
probably a good 'immunohisto logic marker' of a 
cell-mediated (DTH) reaction in intestinal 
tissues [101,102,104], although the secondary 
role of such expression by enterocytes (e. g., in 
local antigen pre sentat ion [9,10]) is not 
entirely straightforward and awaits further 
detailed clarification. However, it seems 
reasonable to conclude from observations based 
on GVHR models that class II antigen expression 
neither ( i) implies nor (ii) inevitably results 
in, enterocyte damage. 
Despite such a brief description of an 
extensive field of study, important lesson s to 
be drawn are (i) that intestinal damage i s a 
dose-related effect proportional to the degree 
of disparity at the MHC locus (ii) that crypt 
hypertrophy is an early feature of damage in 
mild lesion s, in which normal-appearing villi 
may be infiltrated by small, non-mito tic 
lymphocytes (iii) that villous flattening occurs 
late and is T-cell dependent (iv) that t he 
delayed appearance of blast-like, mitotic EL is 
delayed and (v) that lesion development is 
dependent on DTH effector lymphocytes restricted 
by MHC class II antigens . 
The I11111unopathologic Spectrum of Cell-Mediated 
Intestinal Damage 
In the above summary, we can recognise t he 
str uctural features already recognised in 
var ious human enteropathies, especially CS and 
dermatitis herpetiformis . The parallelism not 
only suggests a common immunopathogenic 
mechanism, but also that there are varied and 
progressive structural facets of cell-mediated 
immune damage to the small intestinal mucosa. 
There are additional features common to 
both, such as (i) the constitutive expression by 
villous and crypt enterocytes of MHC Class II 
antigens, (ii) the presence of expanded 
populations of mast cells [78,109] and basoph1ls 
[78] within the lamina propria, (i i i) 
alterations in fluid and ion transport by 
epithelium [14,15] and (iv) secondary changes in 
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permeability [8,6] that are probably due to the 
generation of inflammation within the lamina 
[7]. Another feature of altered pathophysiology 
involves changes in the activity of brush border 
enzymes, such as disaccharidases, but the 
mechanisms governing these changes are more 
subtle than the mere presence of immature 
surface enterocytes resulting from an increased 
rate of cell migration [32]. For example, it 
has been shown that varying rates of cell 
migration influence the enzyme maturation 
profile within individual enterocyte s [59]. 
This is clearly a field ripe for further 
explorations. Parenthetically, clinicians might 
also be wary of jumping to the obvious 
conclusion that gluten is directly damaging to 
surface enterocytes in CS : there is likely to 
be a less facile explanation for such events. 
In considering enterocyte damage, it is 
noteworthy that even in the most severe GVHR 
reactions, such damage i s not always 
conspicuou s, despite (i) the presence of 
increased numbers of EL and (ii) the boosting of 
non-specific T cell cytotoxicity and NK cell 
activity. In this context, the fact that CS 
crypts conta in a 5-6 fold increase in EL should 
not be forgotten [19]. These EL are identical 
to those in surfac e epithelium by a variety of 
criteria [104,73,81]: yet if they are cytotoxic 
to surface enterocytes, it is strange that crypt 
epithelium remains completely unscat hed, and i s 
neither inh ibited in it s vast hypertrophic 
response nor ability to generate argentaffin, 
goblet and Paneth cells. Furthermore, the 
constitutive expression of MHC Class II antigen 
by crypt cells clearly does not le ad to their 
'autoreactive' destruction. 
The ro le that changes in microvascular 
perfusion of the mucosa may play in regulating 
the functional and structural integrity of 
enterocytes must also be considered. These 
aspect s of pathophysiology have not been well 
explored, although ultrastructural le s ions 
documented within CS enterocytes are highly 
reminiscent of those evoked by short -term 
ischemia/anoxia in experimental animals [70,71]. 
CS occurs in genetically-predisposed indivi-
duals (Al, 88, 0R3/7, DQw2) as a resu lt of wheat 
ingestion. Exte nsive studies of the target 
tissue of injury - the upper jejunal mucosa -
have provided important in sights into the 
immunopathology of the lesion . Analogous studies 
of other presumptive "immunological" entero-
pathies such as tropical sprue [77,98], 
giardia sis [1,119], and short-lived reactions to 
various food components (cow's milk protein, 
soya, eggs and fish) in young infants have 
revea l ed similar patterns of intestinal injury 
which, in part, are consistent with a 
cell-mediated form of intestinal injury [50]. 
It also appears that each of these condi-
tions requires ·a specific genetically-determined 
host response to the relevant environmental 
immunogen, whether that be antigen(s) of 
microbial / parasitic origin, food-derived, or 
resulting from discordances at the MHC class 
I / II loci in allograft rejection or GVHR. The 
role of genetic factors in CS/DH has been 
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Figure 18 . The degree of intestinal damage 
caused by pre sumptive cell-mediated immune 
responses to a variety of unrelated 
environmental stimu li is likely to be regulated 
by host responses . Despite these varied 
stimuli, the actual immunopathology observed in 
affected mucosae is stereotyped and appears to 
evolve through a series of recognisable changes 
and pattern s of injury. 
reasonably well documented, but we also know 
that giardiasis is dependent on genetic factors, 
both in humans where HLA-812 may be relevant 
[96], and in animals since BALB/c mice rapidly 
clear the para s ite while C3H/He mice (like T 
cell deficient animals) have defective 
elimination mechanism(s) [114] . Conversely, 
there is no available evidence for tropical 
sprue, but since this condition does not affect 
all those wholly exposed to the same 
environment, some restrictive element must be 
operative and thus presumed to be host-derived 
(Fig . 18). 
The various immunopathologic studies 
referred to above have helped to bring such 
apparently diverse conditions within a unitary 
model of pathogenesis. This framework seems now 
to be well established and provides the data 
required for recognizing either the "early" or 
"late" phases of such reactions within human and 
non-human intestinal tissue. For the future, 
work concerned with the elaboration of 
lymphokines, interferons and leukotrienes, as 
well as other cell-derived factors from mast 
cells, basophils, macrophages and lymphoid 
cells, and the ro le of the neuroendocrine 
system, will need to be unravelled in order to 
further promote our understanding of these 
complicated tissue reactions. 
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chal leng e? 
Discussion with Reviewers 
Does age have an influence on 
indices, particu l arly on mucosal 
volumes and on lymphocyte 
In untreated CS, and after 
Author: In an extensive study of various 
control groups, whose ages range over five 
decades of adult life, no effect of age on 
either mucosal compartment volumes, or on their 
contained EL populations, has been apparent. We 
find that the same indice s in childrens' mucosae 
also are commensurate with those of adults. 
J.R. Poley: Was there adequate sampling of 
biopsy speci mens to exclude the presence of 
so-ca lled patchy le sio ns? 
Author : Patc hine ss of the mucosa l lesion only 
occurs in about 20% mucosae from either 
untreated DH, or CS patients. My opinion is 
that far too much emphasis on mucosal patchiness 
has been made than is warranted by the facts, 
which have been consistent in three independent 
published studies [123,128,129]: it does not 
appear to have had much effect on the 
consistency of our results, as described above. 
J.R. Poley : What is the nature of the 
lymphocyte s - cytotoxic, NK, CD4 or CD8 cells? 
Author: I assume that this query relates both 
toEL (i) normally pre sent within surface and 
crypt epithelium and (ii) to those induced by 
gluten chal leng e. In both circumstances [te xt 
refs. 29, 104] the majority of EL bear the CD8 
antigen. Whether more subt le changes in EL 
populations occur after challenge has not been 
investigated in depth. Furthermore, the 
avai labil ity of newer sub-subset markers 
provides an opportunity for further deta iled 
stu dy on this point. 
A. Fergus on: You have used your technique to 
sca le up cry pt volumes fro m normal mucosae to 
the level seen in CS and shown that the size of 
the revised EL population sti ll falls short of 
th at in the untreated CS crypts, indicating that 
the marked increase of EL in the latter is not 
merely an effect of crypt hypertrophy. In other 
words there is an 'excess' of EL that is trul y 
gluten-induced [ text ref. 79]. I f you were to 
sca le up the reduced surfa ce epithelial volumes 
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Figure 19. Values of VsE obtained for 14 
untreated CS flat mucosae, and 15 untreated flat 
DH mucosae were individually scaled up to a mean 
contro l value of 2.5 x 106µm3 (horizontal soli d 
line) . The new proportional val ues for EL 
populations (Nv,sEl obtained by these procedures 
lie above the upper 95% confid ence limit (dotted 
line) for control mucosae. These derived dat a 









Figure 20. For all 32 untreated DH patients, 
the total volume of epithelium (VEP x 106 µm3 ) 
obta ined by summating VsE + VcR per specimen, 
has been plotted. The majority fall within the 
± 95% confidence limits (horizontal paired soli d 
line s) for 30 contro l mucosal specimens. The 
corresponding total EL populations (Nv,EP ), 
re presenting the sum [Nv, sE + Nv CR], lie 
between ±95% confidence limit s (horizontal 
dotted line s) for the same contra l mucosae. 
Although VEP i s fairly uniform throughout the 
entire series, values for Nv,EP corresponding to 
the right-hand 15 flat mucosae, are lower than 
those of the left-hand specimens, thus 
suggesting a greater loss of EL from the 
epithe li um when f l at. 
of untreated CS mucosae to value s approximating 
VsE for control mucosae, is the discrepancy in 
the l ow values for surface EL obliter ated? 
Author : This is an inter esti ng point which our 
model of quantitating mucosal biopsies permits. 
This specific inter vention had not been carried 
out, but the results sought by this question, 
both for 14 untreated CS patients, and for the 
15 DH patients with f l at mucosae (Fig . 9), are 
shown (Fig. 19). Each mucosa has been sca le d up 
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to a value for VsE of 2.5 x 10 µm, which is the 
mean for 30 controls (10 young healthy 
volunteers + 10 healthy CS relatives + 10 
disease-contro l patients without mucosal 
abnormality), and the corresponding new values 
for Nv,sE displayed on a logarithmic scale. The 
majority of values for Nv,sE lie above the 95% 
upper confidence limit for control EL 
populations in villous surface epithelium. We 
are back to the Type 1 lesion! 
D. Moffitt : From Fig . 9, the impression is also 
gained that there is no overall change in tota l 
epithelia l volume (VsE + VcR = VEP) and that the 
total EL population (Nv,SE + Nv,cR) may also not 
vary. If so, this suggests that the conformation 
of the mucosa (villous to avillous) and type of 
EL present (small, non-mitotic, to large and 
mitotic) are the basic changes present. 
Furthermore, high EL mitotic activity with 
little change in absolute count implies either 
increased lo sses into the intestinal lumen or 
increased trafficking back into the lamina 
propria. Does this conf lict with the conclusion 
that the density of EL increases with mucosal 
flattening? 
Author: By summating the values (VsE + VCR) and 
~ + Nv,cR) , it can be seen (Fig. 20) that 
total epithelial volume in the 32 untreated DH 
patient s (text Fig . 9) fall s within the upper 
and lower 95% confidence limits for the 30 
varied contro l mucosae referred to in the answer 
to the preceding question. Furthermore, the 
total EL population tends to lie about the upper 
95% confidence limits es tablishd for the 30 
control mucosae, although for the flat mucosae 
(r ight-hand 15 values) Nv,EP drifts downwards , 
again suggesting a net loss of EL in the most 
seve rely damaged mucosae. The fall in the 
absolute number of EL (Nv, sE ) in sur face 
epithelium is a real phenomenon and does not 
conflict with the fact that their density is 
increased - it depends on what is being measured 
and how those measurements are interpreted (see 
Fig. 16): my data suggest a considerable loss of 
EL occasioned by the increased dynamic state of 
epithelial cell turnover when the mucosa is 
flattened . 
Note that although total epithelial volume 
is unchanged, the ratio of crypt to surface 
epithelia l cells rises. Since the functions of 
these two population s of cells are different, 
the digestive-absorptive capacity of a flattened 
mucosa is considerably disturbed because of (i) 
mucosal flattening per se (ii) damage to the 
surface enterocytes and (iii) rapid migration of 
cel l s, leading to (iv) a higher proportion of 
'immature' cells lining the luminal surface. 
Teleologically it can be seen that in the 
process of becoming flat we have an adaptive 
respo nse that reduces antigenic exposure and 
uptake, as possibly limits the surface available 
for colonization, for example, by worms or 
parasites. 
A. Ferguson: The proliferative compartment in 
CS mucosae is greatly expanded relative to the 
overa ll size of the crypts. Is there any 
particular pattern in the distribution of EL 
between the proliferative, and maturational, 
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compartments? 
Author: This distinction has not been formally 
evaluated. EL occur more in the upper one-half 
of the crypts and therefore would extend right 
across the maturational zone from the sur face 
downwards and into the proliferative zone. I 
think there is a closer relationship between the 
presence of EL and the expression of MHC class 
II antigen by crypt enterocytes - although which 
comes first and to what degree there is a 
functional connection [124], requires further 
analysis. 
A. Ferguson: In untreated DH patient s and in 
the first degree CS relatives without 
enteropathy, have you considered whether these 
represent one end of a bimodal distribution in 
comparison with all others who form a continuum 
from marginal to unequivocal enteropathy 
together with their abnormalities of EL 
populations? 
Author: I doubt whether we are seeing a bimodal 
population . The DH cases you refer to (first 
seven cases on left-hand side of text, Fig. 9) 
and the subgroup of first-degree CS relatives, 
have entirely normal morphology except for the 
singu lar presence of an increased population of 
small, non-mitotic EL in surface (vi ll ous) 
epithelium . Identical changes were induced with 
oral challenge (O.l-l.5g FF3) (Fig . 11) but 
since a larger dose oral challenge evoked the 
sequentia l appearances of type 1 and then type 2 
lesions during a 5-day period of observation 
(Fig. 12), it seems evident that all three 
distinct pi ctures are successive phases in the 
evolution of a flat mucosa. However, in our 
challenge studies we were careful to use only 
patients previously known to have a flat biopsy. 
Whether those particular DH patients and CS 
relatives could be stimulated on challenge to 
produce a more severe type of lesion is not 
known. It i s conceivable that such individuals 
are genetically restricted from proceeding 
further along the evolutionary pathway 
described. This i s an important point which 
needs to be tested. 
A. Ferguson: In the gluten-challenge series, it 
is presumed that the controls were inges ting a 
normal diet containing substantial amounts of 
gluten, and that the treated coeliac patients 
were taking milk providing a substant ial amount 
of B-lactoglobulin. Although I do not think 
this is likel y, presentation of antigen not 
encountered for many years and in the absence of 
blocking antibody might theoretically induce the 
effects observed. Were level s of local 
secretory, or syste mic, anti-gliadin antibodies 
by any chance measured in these patients before 
challenge? 
J.R. Poley: Were any of 
followed by serologic tests 
anti-endomysial antibodies) 
morphologic findings? 
the CS patients 
(anti-gl iadin and 
to parallel 
Author: Such antibody levels were not studied 
before challenge. However, by challenging 
controls and CS patients with gluten and 
B-lactoglobulin (on separate occasions) and 
showing that only CS patients responded to 
gluten, it was felt that a specific, immunologic 
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response had been obtained. In subsequent work, 
we have tried to impose a milk-free diet on 
controls before challenge, but they have not 
been at all keen to do that, so that in 
practise, it is not easy to induce patients to 
confirm to what, admittedly, is a more ideal 
experimental settin g for these challenges. 
A. Ferguson: Another very critical point 
concerns whether all the effects, particularly 
the later ones, can be attributed to the gluten 
challenge itself, or whether an initial 
abnormality produced by the immunopathologic 
effect of gluten leads to the evolution of a 
range of secondary, non-specific immune and 
other reactions that extend, and amplify, the 
effects of the gluten-targetted immune response. 
Although difficult for the patient, it would be 
interesting to maintain the patient on an 
elemental diet following challenge for the 
remainder of the study: predict that the 
enteropathy would resolve rapidly within 24-48h. 
Author: We have not done this, although the 
point you raise is of considerable theoretical 
interest. It might be possi ble to incorporate 
this modification into our chal lenge protocol 
and compare results with our 'standard' 
challenge at each dose level of gluten employed. 
Incidentally, it may not have been apparent, but 
all CS patient s remained 'gluten-free' throughout 
each series, except for the single challe nge 
dose of FF3. 
A. Ferguson: The late appearance of lymphocytes 
with mitoti c activity in the infiltrates in 
various situations is fascinating. Thi s could 
be explained by different stimuli producing 
mitosis in the population of precursor Els and 
allowing enhanced migration /acc umulation of EL 
within the epithelial microenvi ronment, 
irrespective of mitotic activity. If humans are 
analogous to mice, one would expect a 2-3 day 
delay between antigen re-exposure and the 
appearance of ce ll s within the gut which had 
·been stimulated within Peyer's patches migrating 
via lymph and bloodstream. 
Author: It was previously shown [te xt ref. 66] 
ttiatthe ratio of EL traversing the basement 
membrane to those within epithelium ("Flu x 
Ratio") was elevated, suggesting increased 
lymphocytic trafficking across the basement 
membrane in untreated CS mucosae, compared with 
controls. My own feeling i s that because of the 
extremely accelerated loss of surface 
enterocytes from flat untreated CS mucosae, the 
tempo of movement of lymphocytes into epithelium 
is increased to "make good" their continuing 
loss into the lumen: hence also the raised flux 
ratios. In this regard, I believe that the 
large EL that appear at this time are not 
immunoblasts, but may be large immature cells 
(i.e. lymphoblasts) reflecting the high 
proliferative rate of precursors necessary to 
maintain the size of the EL population 
(analogous to the presence of large nucleated 
precursors of erythroid and myeloid cell lines 
in haemolysis, or leucocytosis, respectively). 
The absence of activation markers [127] on these 
large EL (i.e. Tac or transferrin) also suggests 
that they may not be immunoblasts. Furthermore, 
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if they did reflect gluten-triggering of 
gluten-sensitised EL, then they should also be 
see n in the earlier 'proliferative' (Type 1) 
lesion, but here they are conspicuously absent, 
despite the fact that these infiltrate s are 
gluten-dependent. In this respect, it is correct 
to suggest that these high infiltrate s may be 
due to antigen-induced lymphocyte retention 
within the epithelium. It therefore follows 
that, if the epithelium was not subject to 
destructive influences (Type 2 lesion), the 
established flat CS surface epithelium would 
also contain an elevated EL population (Fig. 
19): the postulated high turnover of EL into 
epithelium in this situation might therefore be 
geared up to attempt this - although in reality 
this aim is hardly achieved. 
A. Ferguson: I completely agree with the 
concept that there is an early phase of 
coeliac-like enteropathy in which EL 
infiltration and crypt hyperplasia are 
predominant and that vil lus atrophy is a 
distinct and separate later phenomenon. It is 
only in the villus atrophy phase that there i s 
obvious enterocyte damage. I think I am right in 
the assumption that there are no features of EL 
to differentiate between these two states, and 
that you would agree that some factor other than 
T cell mediated damage is likely to be the 
explanation for the villus enterocyte 
abnormalities. You published some years ago on 
the sub-epithelia l fibroblast sheath, and you 
have made many observations on the connective 
tissue and vascular components of the lamina 
propria, in addition to the infiltrating cells. 
Have you any comments on abnormalities of these 
structures, or of the basement membrane, which 
may be relevant to the enterocyte damage? Might 
there be relative ischaemia at villus tips? 
What about immune complexes? 
Author: The only differences in EL between the 
proliferative (Type 1) and destructive (Type 2) 
lesion are the increased size of population of 
EL in the former, and the relative increase in 
their diameters in the latter: additional TEM 
studie5 would not provide differential 
infor mati on. With regard to the mechanism of 
enterocyte damage, it is clear that EL do not 
appear to be relevant factors, since they 
evidently cause no obvious damage to the mucosa 
in the Type 1 le sion. Furthermore their 
sustained increase in the cry pts of Type 2 
lesions without apparently affecting the high 
rate of crypt ce ll division; cry pt hypertrophy; 
migratory capacity; ability to cytodifferentiate 
into Paneth cells, argentaffin and goblet cells 
and their continued ability to synthesise and 
express MHC class II glycoproteins, is al so 
indicative that EL are not agents of mucosal 
destruction, as I have consistently argued 
elsewhere [text ref. 73,79]. My own view is 
that ischemia may be a very relevant factor that 
leads to impaired surface enterocyte structure 
and function. Another second factor of 
importance may be the release of connective 
tissue and basement membrane-degrading enzymes 
from neutrophils and mast cells that constit ute 
some of the major cell infiltrates within lamina 
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propria [text ref. 23,78]. The effect of these 
enzymes is probably to weaken the attachment of 
surface enterocytes to the basement membrane and 
thus impair their viability. These points have 
been explored, together with the role of 
antigen-a~tibody complexes, elsewhere [text ref. 
70,71], but I have no firm data at this time. 
A. Ferguson: Were there differences in lamina 
propria cell density when the coeliac relatives 
with abnormalities of EL were compared with the 
ot her s? 
Author: Unfortunately this was not done. Since 
these specimens were formalin-fixed/wax-
embedded, the chances of doing good image-
analysis on such material, especially within the 
lamina, would be very low. 
A. Ferguson: In discussing these coeliac 
relatives and also the DH patients, the 
important variable, of dietary gluten intake, 
has not been considered. There either may be a 
variable tissue reaction, which is pathological, 
to standard dietary gluten in about one third of 
coelia c relati ves and the majority of DH 
patients; or within a fairly uniform population 
of gluten sensitive individuals, tissue changes 
reflect fairly accurately the dietary gluten 
intake of the previous couple of weeks. I may 
say that we are in the process of analysing 
jejunal biopsy data from a large number of DH 
patients and have found not only minor 
abnormalities of histology, particularly of EL, 
but also a very high proportion with abnormal 
intestinal permeability even when jejunal biopsy 
morphology is essentially normal. 
Author: This raises a very important point, but 
Tsan aspect of research in this field that is 
rarely considered. Nevertheless, it would be 
very difficult (a) to control and (b) to 
determine the actual daily dietary intake of 
gluten per person. Dose of gluten may be 
important, as revealed for the first time in our 
carefully-monitored, sequential challenges with 
FF3. Having said that, I am certain that on 
average, each person's daily intake of gluten is 
fairly constant and it may also be true for the 
whole population that person-to-person 
variations in daily gluten intake may not vary 
to any great extent. This has never been 
investigated, to my knowledge. Furthermore I 
doubt, for example, whether the intake of gluten 
varied much in the patient (Fig. 13) whose 
mucosa was observed to slowly flatten over the 
course of about 3 years. This raises another 
new question as to what factor(s) controlled the 
slow evolution of her mucosa] lesion. 
I think you are right about DH patients -
all our DH patients had increased mucosal 
permeability to Cr-EDTA [text ref. 8] even 
after they had been on a gluten-free diet for a 
reasonable period (in some cases, several 
years). It is also my impression that the 
inflammatory response in DH mucosae is 
considerably more vigorous than in CS patients, 
even though their degree of mucosal 
architectural distortion is considerably less . 
This also suggests a multiplicitiy of operative 
pathogenetic mechanisms, ie, a basic T-cell 
mediated response that determines the degree of 
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mucosal architectural disruption (? determined 
by host MHC class II) upon which other secondary 
inflammatory- or cytokine-driven responses may 
be enacted. 
A. Ferguson: It is conceivable that dietary 
gluten induces a state of suppressed mucosal 
immunity. Thus, if normal people (or people 
incorrectly diagno se d to have celiac disease) 
were maintained on a gluten-free diet for a 
prolonged period, an altered capacity to 
subsequently respond to any antigen, including 
gluten, might be observed. 
Author : We have not challenged any person 
falling into the category suggested. The 
proposal, however, is intere sting in terms of 
orally-induced tolerance and the influence of 
prolonged dietary antigenic restriction on 
mechanisms of local immune suppression. 
J.R. Poley: Not mentioned are possibilitie s of 
lectin-mediated damage of small bowel mucosa, 
which has been postulated by several groups as an 
important pathogenic mechanism, and this reviewer 
believes that such hypothesis should be included 
in the di scussion. 
Author: I note your use of the word 
'postulated'! The theory that gluten might act 
as a "lectin" (in other words, attach itself to 
some kind of cell receptor) was proposed over 
ten years ago [130]. It was supported by the 
i solation of a glycopeptide shown to damage CS 
mucosa [125], that damage being caused by gluten 
attachment to an abnormal receptor expressed by 
surface enterocytes in such patients. Another 
group implied that crypt enterocytes (admittedly 
from rats - if thTsTs at all relevant) bind 
gluten via oligomannosyl residues [126]. It is 
my guess that we all suspect there are receptors 
on cells that bind gluten, although I am not 
clear as to why such receptors have to be 
aberrant. But if this is so, why glorify that 
principle into a new theory of pathogenesis? 
Surely we just have to get on and determine the 
character istic s of the relevant receptor. Nor 
does it follow that attachment of gluten to the 
membrane should necessarily cause that cel l to 
be ki lled, which is a corollary of the proposal. 
Finally, these notions have to be squared with 
all the immunopathologic features of gluten 
sensitivity described in this paper . The latter 
fit more easily into the scheme of a 
cell-mediated immune response rather than to 
some unproven ideas about an abnormal cell 
receptor. 
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